Browse: Departments Dates Agencies
SUBJECT CATEGORY: National Institute of Environmental Health Sciences; Notice of Closed Meeting
DOCUMENT SUMMARY:
Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. appendix 2), notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Environmental Health
Sciences Special Emphasis Panel, Development and Validation of High
Throughput in Vitro Estrogen Receptor (ER) and Androgen Receptor (AR) Binding Assays.
Date: February 19, 2004.
Time: 1 p.m. to 4 p.m.
Agenda: To review and evaluate contract proposals.
Place: NIEHS/National Institutes of Health, Building 4401, East Campus, 79 T.W. Alexander Drive, 122, Research Triangle Park, NC 27709 (Telephone Conference Call).
Contact Person: RoseAnne M. McGee, Associate Scientific Review
Administrator, Scientific Review Branch, Office of Program
Operations, Division of Extramural Research and Training, Nat. Inst.
of Environmental Health Sciences, P.O. Box 12233, MD EC30, Research Triangle Park, NC 27709, 919/5410752.
(Catalogue of Federal Domestic Assistance Program Nos. 93.115,
Biometry and Risk EstimationHealth Risks from Environmental
Exposures; 93.142, NIEHS Hazardous Waste Worker Health and Safety
Training; 93.142, NIEHS Superfund Hazardous SubstancesBasic
Research and Education; 93.894, Resources and Manpower Development
in the Environmental Health Sciences; 93.113, Biological Response to
Environmental Health Hazards; 93.114, Applied Toxicological Research and Testing, National Institutes of Health, HHS)
Dated: December 17, 2003.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 0331560 Filed 122203; 8:45 am]
BILLING CODE 414001M
SUMMARY: National Institute of Environmental Health Sciences,
DOCUMENT BODY 2:
Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. appendix 2), notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Environmental Health
Sciences Special Emphasis Panel, Development and Validation of High
Throughput in Vitro Estrogen Receptor (ER) and Androgen Receptor (AR) Binding Assays.
Date: February 19, 2004.
Time: 1 p.m. to 4 p.m.
Agenda: To review and evaluate contract proposals.
Place: NIEHS/National Institutes of Health, Building 4401, East Campus, 79 T.W. Alexander Drive, 122, Research Triangle Park, NC 27709 (Telephone Conference Call).
Contact Person: RoseAnne M. McGee, Associate Scientific Review
Administrator, Scientific Review Branch, Office of Program
Operations, Division of Extramural Research and Training, Nat. Inst.
of Environmental Health Sciences, P.O. Box 12233, MD EC30, Research Triangle Park, NC 27709, 919/5410752.
(Catalogue of Federal Domestic Assistance Program Nos. 93.115,
Biometry and Risk EstimationHealth Risks from Environmental
Exposures; 93.142, NIEHS Hazardous Waste Worker Health and Safety
Training; 93.142, NIEHS Superfund Hazardous SubstancesBasic
Research and Education; 93.894, Resources and Manpower Development
in the Environmental Health Sciences; 93.113, Biological Response to
Environmental Health Hazards; 93.114, Applied Toxicological Research and Testing, National Institutes of Health, HHS)
Dated: December 17, 2003.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 0331560 Filed 122203; 8:45 am]
BILLING CODE 414001M
14 CFR Part 39 40 CFR Part 52 14 CFR Part 71 33 CFR Part 165 50 CFR Part 679 47 CFR Part 73 26 CFR Part 1 40 CFR Part 180 33 CFR Part 117 50 CFR Part 17 44 CFR Part 67 50 CFR Part 648 14 CFR Part 97 33 CFR Part 100 40 CFR Part 63 50 CFR Part 622 44 CFR Part 65 50 CFR Part 660 26 CFR Part 301 39 CFR Part 111 40 CFR Part 300 6 CFR Part 5 40 CFR Part 271 47 CFR Part 64 40 CFR Parts 52 and 81 50 CFR Part 665 44 CFR Part 64 10 CFR Part 50 49 CFR Part 571 47 CFR Part 76